Merck & Co., Inc. (NYSE:MRK) Hits New 12-Month High After Analyst Upgrade
Merck & Co., Inc. (NYSE:MRK – Get Free Report) shares hit a new 52-week high on Tuesday after Argus raised their price target on the stock from $145.00 to $170.00. Argus currently has a buy rating on the stock. Merck & Co., Inc. traded as high as $155.10 and last traded at $153.6550, with a […]
25 Aug 14:20 · The Markets Daily